Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Arnaud Debin"'
Autor:
Virginie Pascal, Brice Laffleur, Arnaud Debin, Armelle Cuvillier, Marjolein van Egmond, Daniel Drocourt, Laurent Imbertie, Céline Pangault, Karin Tarte, Gérard Tiraby, Michel Cogné
Publikováno v:
Haematologica, Vol 97, Iss 11 (2012)
Background While most antibody-based therapies use IgG because of their well-known biological properties, some functional limitations of these antibodies call for the development of derivatives with other therapeutic functions. Although less abundant
Externí odkaz:
https://doaj.org/article/229e9afd88c64c1d9f457da071b1f191
Publikováno v:
Nucleic Acids Research. 27:2699-2707
In this work we selected double-stranded DNA sequences capable of forming stable triplexes at 20 or 50 degrees C with corresponding 13mer purine oligonucleotides. This selection was obtained by a double aptamer approach where both the starting sequen
Autor:
Laetitia Hellaudais, Muriel Golzio, Jean-Michel Escoffre, Daniel Drocourt, Gérard Tiraby, Arnaud Debin, Jean-Paul Reynes, Justin Teissié
Publikováno v:
Technology in Cancer Research and Treatment
Technology in Cancer Research and Treatment, 2008, 7 (2), pp.109-116. ⟨10.1177/153303460800700203⟩
Technology in Cancer Research and Treatment, Adenine Press, 2008, 7 (2), pp.109-116. ⟨10.1177/153303460800700203⟩
Technology in Cancer Research and Treatment, 2008, 7 (2), pp.109-116. ⟨10.1177/153303460800700203⟩
Technology in Cancer Research and Treatment, Adenine Press, 2008, 7 (2), pp.109-116. ⟨10.1177/153303460800700203⟩
RNA interference appears as a promising tool for therapeutic gene silencing. A key limit is the delivery of the siRNA. A safe approach is to use a physical method such as in vivo electropulsation with contact electrodes. Getting a long lived silencin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e32c154a1fffc4834d116c2e3c3626e
https://www.hal.inserm.fr/inserm-02439064
https://www.hal.inserm.fr/inserm-02439064
Autor:
Sandrine Sperandio, Arnaud Debin, Karl Melber, Marinette Moynier, Laurence Cazales, Didier Betbeder, Zbigniew A. Janowicz, Jocelyn Vaz Santiago, Roger Kravtzoff
Publikováno v:
Vaccine. 20(21-22)
New cationic nanoparticles (SMBV™) were evaluated for use as a nasal vaccine delivery system for two recombinant proteins: HBsAg and β-galactosidase. Each protein was formulated with SMBV™ and intranasally administrated to non-anesthetized mice.
In our previous work we have shown that the oligonucleotide 5'-GGGGAGGGGGAGG-3' gives a very stable and specific triplex with the promoter of the murine c-pim-1 proto-oncogene in vitro[Svinarchuk, F., Bertrand, J.-R. and Malvy, C.(1994)Nucleic Acids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c30addd7078ab403fb4347b95b930dd
https://europepmc.org/articles/PMC145626/
https://europepmc.org/articles/PMC145626/
Autor:
Alain Etienne, Arnaud Debin, Yannik Palvadeau, Alain R. Thierry, Dominique Durand, Marc Schmutz
Publikováno v:
Biology of the Cell. 91:276-276